A research team at The Hong Kong Polytechnic University (PolyU) has developed Hong Kong's first "AI Agent for Precision Diabetes Management—PIPE-AI" (AI Agent), designed specifically for Asian ...
Background Adult-onset Still’s disease (AOSD) is a systemic autoinflammatory disorder lacking a gold-standard diagnostic ...
CMS launches Medicare GLP-1 Bridge to offer select beneficiaries fixed-cost access to GLP-1 drugs from July 2026 through 2027.
Objective To investigate the association between attention-deficit/hyperactivity disorder (ADHD) and cardiometabolic risk profile at the time of type 2 diabetes (T2D) diagnosis and examine ...
Introduction Tribal people in India face a growing risk of multimorbidity, primarily from cardiovascular diseases (CVD) due to changing lifestyles and unique socio-cultural and political factors. We ...
PHILADELPHIA.Today on MSN
Wistar Scientists Develop Single-Dose DNA Method for Delivering Long-Acting Weight Loss, Diabetes Drugs
Scientists at The Wistar Institute have shown that a single injection of a small, circular piece of genetic instructions can ...
Adults with type 2 diabetes who were provided medically tailored healthy meals and lifestyle counseling for 6 months had a ...
In The Lancet Diabetes & Endocrinology, Jing Luo and colleagues present the HumAn-1 trial, an important contribution to the literature on type 1 diabetes in low-income and middle-income countries ...
Welcome to the “Temu experience of telehealth,” where everyone from Grindr to MAGA influencers can open a virtual clinic ...
Large language models (LLMs) are rapidly being integrated into clinical workflows, supporting tasks such as diagnosis ...
The supplementary care model encourages use of health tech to boost patient outcomes for prevalent chronic conditions in Medicare patients. This month sees the start of a new Centers for Medicare & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results